Medical Cannabis Distributor

An Australian-owned company founded in 2015, Cannatrek specialise in the research, cultivation, manufacturing and delivery of medicinal cannabis. Backed by medicinal licenses and strategic global partnerships, the Company manages the entire product lifecycle. From growth and processing to distribution and sales, Cannatrek’s ecosystem of suppliers, doctors, pharmacists and patients is integrated by an innovative digital platform delivering information on plant-based therapies to eligible patients. Its unique seed-to-patient model supports the Company in achieving its mission to provide affordable care to patients.

Having established strong relationships with quality offshore producers, Cannatrek is able to offer premium quality cannabis varieties to its customers. Collaboration with established, leading seed banks enable Cannatrek to continuously build a genetic stock foundation of robust and rare genotypes. The Company currently has eight different plant strains and is working to develop new strains through cross-breeding to treat a wider array of medical conditions.

VIC, Australia

Beacon Medical Australia (Beacon Medical) is a wholly-owned subsidiary of Canadian TSX-listed company, VIVO Cannabis (TSX:VIVO), which has been growing and selling pharmaceutical-grade medical cannabis to patients since 2014. VIVO Cannabis hold two of the first sixteen licenses granted to grow cannabis for Canadian medical patients, and Beacon Medical is a conduit for bringing the parent Company’s knowledge, care and compassion to Australian patients.

A name fit for purpose, Beacon Medical aims to be a guiding light for patients. Its indoor, small batch GMP production facilities produce premium quality, consistent products and a set of stringent quality assurance processes set the bar for quality and compliance in medicinal cannabis production. Beacon Medical’s operations house some of the most technologically advanced indoor growing facilities in the world, enabling the Company complete control over the environment and consistency of strains produced.

ON, Canada

Burleigh Heads Cannabis was one of the very first companies in Australia to receive its importation and wholesale license for medical cannabis back in 2017. Since then, it has grown into one of the country’s largest and most well-known wholesalers, selling thousands of products per month to an ever-growing network of pharmacies. Adopting a patient-first philosophy, BHC’s business is built on core values of safety, affordability and reliability.

BHC partners with both domestic and international suppliers to offer pharmacies and their patients the widest range of medical cannabis products available in Australia. This provides a one-stop solution for all ordering and distribution needs.

QLD, Australia

Established in 2020, SunCo Green was formed to address the need for patient access to the clinical benefits of medical cannabis, in addition to providing health professionals with product and industry information and guidance. SunCo Green’s mission is to build a locally owned and operated medical cannabis business in a socially and environmentally responsible way that will be embedded in the Australian cannabis community, plus the wider cannabis industry for years to come.

Based in Queensland's Sunshine Coast with an additional facility in South Australia, the Company offers an array of premium medical cannabis products for prescription and pharmacy customers. SunCo Green maintains that the path to success is through its partnerships with clinical, academic and key industry players. Aiming to provide a high-quality product, SunCo Green’s range is designed to be adaptable to the changing needs of its patients as the experience of its prescribers expands.

QLD, Australia

Cannim is a global cannabis company founded in 2017 that provides GACP and GMP-certified medical solutions to deliver better physical and mental health outcomes for patients worldwide. The Business is built on three core pillars of safety, science and scale, underpinning its sustainable approach to building a global market share and establishing world-leading medicinal cannabis brands.

Since its inception, Cannim has invested in farms in Australia and Jamaica and has built a network of GMP manufacturers and alliances in education and healthcare. Cannim continues to scale its operations, enabling the ability to meet the needs of the ever-growing body of medicinal cannabis users. Pioneering industry development and leading research and education on the effects of medical cannabis, Cannim is creating new ways of administration for patients, ensuring those in need get what they require at a fair price.

NSW, Australia

SatiVite combines decades of sustainable agricultural knowledge, medical cannabis industry expertise, and international business experience to bring patients in Australia superior medical cannabis products. All founders of SatiVite hold formal qualifications in agriculture and have in-depth, hands-on experience in growing medical cannabis, industrial hemp and other crops.

The Company scopes, imports and distributes organically and sustainably grown dried flower and broad spectrum extracts with a range of cannabinoid profiles, as well as premium cannabis-based medicines and administration devices from leading licensed suppliers. As a licensed grower and researcher, SatiVite is developing and cultivating field-grown, high-CBD varieties in Queensland and New South Wales and is ramping up to produce Australian-grown, GMP-certified medical cannabis in its own custom-engineered glass house in New South Wales.

QLD, Australia

A multinational organisation headquartered in Australia, Gamma Biomedical was founded in 2014 to improve access to products and services that weren’t previously available to Australian healthcare providers. The Company holds various medical wholesale licenses covering a broad spectrum of scheduled medicines in Australia. Extensive experience with international health regulations and logistics ensures governmental compliance and seamless supply chains.

In 2018, Gamma Biomedical entered a joint venture with US-based hemp company, Isospec, to create a range of Australian-specific CDB products, including Australia’s first line of flavoured oil and topical preparations. Developed in collaboration with athletes, physicians and scientists, the Isospec range is designed to maximise natural healing and recovery. From seed to final finished product, control is ensured at every stage of the process enabling constant improvement and innovation. Manufacturing under stringent GMP controls helps guarantee a premium therapeutic product for patients.

QLD, Australia

Cymra Life Sciences is an Australian-owned medical cannabis cultivator and manufacturer located in Byron Bay, NSW. Established in 2017, its founders set out to improve the lives of patients through affordable, high-quality GMP medicines grown and manufactured in Australia. In addition, Cymra Life Sciences is on a mission to provide evidence that supports cannabis as a replacement for opiates.

The Company cultivates full spectrum products that are more like the plant, including terpenes and other beneficial compounds which are specialised to enhance the lives of people living in chronic and neuropathic pain. Cymra Life Sciences was one of the first Australian companies to develop medical cannabis through tissue culture propagation, a method that delivers a consistent, natural product free from chemicals and pesticides. Organic farming practices produce high-quality flower and ingredients that provide patients with the cleanest, safest and most effective products on the market.

NSW, Australia

Tikun Australia is an Australian owned licensed cultivator of medical cannabis supported by global research into plant science, manufacturing and therapeutic outcomes. The team at Tikun Australia is passionate about helping patients in need and alleviating the impact of a multitude of diseases and conditions. They are committed to providing Australian patients with greater opportunities to acquire high quality Australian cultivated and manufactured products.

Located on the Sunshine Coast in Queensland, the Business leverages its counterpart, Tikun Olam’s, substantial experience in the industry to produce premium products that target symptomatic relief for Australian patients. Tikun Olam, a global company launched over 15 years ago, is a pioneer in medical cannabis research, has performed extensive clinical trials and has assisted over 30,000 patients through its broad network of clinics.

QLD, Australia

Located in Barangaroo, NSW, Aruma Labs is a fully licensed Australian life sciences company that provides medicinal cannabis for people living with chronic illness. Driven by a passion for helping others, quality and patient care are at the forefront of the Company’s priorities. It continuously seeks to develop products and solutions that support positive health outcomes and treat unmet medical needs.

The Company develops, produces and distributes high-quality cannabinoid-based therapeutics that are manufactured to GMP standards. Each product passes through rigorous quality assurance assessments, including independent, third-party testing to meet strict Australian pharmaceutical standards. Aruma Labs also provide education and tools for healthcare providers to seamlessly integrate medicinal cannabis into clinical treatment plans for patients with chronic health conditions.

NSW, Australia

Based out of Lincoln University in New Zealand, Greenlab is placing the country at the forefront of medical cannabis research, production and manufacturing. Built on a mission to be an international player in cannabinoid-based medicine, Greenlab’s principal goal is to fast track research, create intellectual property and supply GMP-grade pharmaceutical products to the emergent markets in New Zealand, Australasia and North America.

The Company has received required licenses to implement research into optimising the cultivation process of medicinal cannabis, intending to reduce the cost of production, increase yield and fasten growth cycles. Greenlab’s state of the art growing facility enables the Business to apply its cultivation research effectively in an indoor, purpose-built environment. Access to unique germplasm allows the selection of elite medical cannabis clones to yield therapeutically active major and minor cannabinoids. Additionally, sophisticated intellectual infrastructure enables optimisation of agronomic parameters for elite medicinal cannabis chemovars. The Company is also committed to finding ways to transform cannabis waste value into added products.

VIC, Australia

Since launching in 2018, Bloom Pharms has had one simple goal – to create high-quality medical cannabis products. Its aim is to revolutionise health by empowering people to take control of their health and wellbeing. By leading the way forward in education and product quality, Bloom Pharms hope to remove the stigma of cannabis and hemp by educating people on alternative health options.

From seed to shelf, the Company seeks to always maintain ethical practices. Bloom Pharms values where its products come from, as well as how they are farmed and processed. In an effort towards encouraging holistic land management and regenerative agriculture, it also actively supports certified organic and biodynamic farms. Its Pure Infusion range contains all-natural, nutrient-dense CBD oil products that are unique to the market with no chemicals or solvents used in the process. This CBD oil has an array of natural terpenes and chlorophyll, giving the oil its signature green colour.

NSW, Australia

As an Australian cultivator, producer, manufacturer, exporter and researcher of premium cannabinoid-based therapies, Medibis is committed to delivering high-quality medicines to patients. With a passion for providing patients with the best medicine made from the best cannabis, it is focused on delivering treatment solutions using cannabinoids, flavonoids and terpenoids without the use of any nasty chemicals. Medibis is committed to providing scientific, evidence-based solutions through the research and development of medicinal cannabis to support new global treatment methods and quality of life standards.

Through research initiatives, Medibis is focused on uncovering insights into medical cannabis including phytocannabinoid therapies and the endocannabinoid system. This research, combined with cutting-edge technologies helps it deliver end-to-end solutions for clinicians and patients. With innovation to help progress cannabinoid therapy as an adjunct and disruptive treatment, Medibis is dedicated to revolutionising healthcare and transforming quality of life standards for Australian patients.

QLD, Australia

TAS, Australia